COMPANY PROFILE / #1304
DeepCure
Boston, MAVenture Capital-Backed
OVERVIEW
Developer of a drug discovery platform designed to improve the breadth and accuracy of pre-clinical drug development. The company's platform combines deep learning algorithms, cloud computing infrastructure, and a proprietary database of chemistries to find drug candidates that deliver improved value to patients, enabling scientists and healthcare professionals to create better molecules and faster cures for every disease-relevant protein target.
已融资71.42
最新估值200.00
员工数31
成立年份2018
公司概况
- Companies
- DeepCure
- Description
- Developer of a drug discovery platform designed to improve the breadth and accuracy of pre-clinical drug development. The company's platform combines deep learning algorithms, cloud computing infrastructure, and a proprietary database of chemistries to find drug candidates that deliver improved value to patients, enabling scientists and healthcare professionals to create better molecules and faster cures for every disease-relevant protein target.
- Website
- deepcure.com
- HQ Location
- Boston, MA
- Year Founded
- 2018
- Keywords
- biotechnology platform, computational chemistry, drug development system, precision therapeutics, small molecule, small molecule therapy
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 71.42
- First Financing Date
- 01-Jan-2018
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- —
- Last Financing Deal Type
- Accelerator/Incubator
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 200.00
- Last Known Valuation Date
- 11-Apr-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 278.67
- Valuation Estimate Growth Rate
- 39.33%
- Active Investors
- 5Y Capital, Benon Group, C2I Accelerator, Calvin Chin, Creative Destruction Lab, E14 Fund, IAG Capital Partners, Industrial Liaison Program, Massachusetts Institute of Technology, Morningside Group, Sapir Venture Partners, TLV Partners
- # Active Investors
- 12
- Acquirers
- —
团队与联系人
- Employees
- 31
- Employee Growth %
- -8.82%
- Employee History
- 2026: 31, 2025: 34, 2024: 49, 2023: 39, 2022: 35, 2021: 24, 2020: 13, 2019: 9
- Primary Contact
- Kfir Schreiber
- Primary Contact Title
- Co-Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- kfir.schreiber@deepcure.ai
- Primary Contact Phone
- +1 (857) 209-1916
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 17%
- Success Probability Over Time – 3 Year
- 41%
- Success Probability Over Time – 5 Year
- 53%
记录来源：public.companies · 原始序号 #1304 · 所有字段均按数据库原值展示。